Yearly Archives: 2012

StopAfib.org - For Patients. By Patients - Stop Atrial Fibrillation

Eliquis (apixaban) approved by US FDA for atrial fibrillation stroke prevention

Press Release: Bristol-Myers Squibb and Pfizer Announce U.S. FDA Approval of ELIQUIS® (apixaban) Friday, December 28, 2012 5:46 pm EST PRINCETON, N.J. & NEW YORK--Bristol-Myers Squibb Company (NYSE: BMY) and Pfizer Inc. (NYSE: PFE) today announced that the U.S. Food and Drug Administration (FDA) has approved ELIQUIS® (apixaban). Please see full Prescribing Information including BOXED WARNING and Medication Guide …

Read More
StopAfib.org - For Patients. By Patients - Stop Atrial Fibrillation

Top Atrial Fibrillation (Afib) Videos of 2012

StopAfib.org is pleased to unveil the Top Ten Atrial Fibrillation Videos of 2012. This year the FIRM ablation interviews with Dr. Narayan topped the list. Other popular topics included stroke prevention, new afib guidelines, sleep apnea, and medications. Stories about efficacy of catheter ablation and surgical procedures, comparisons of rate and rhythm control, and other …

Read More
StopAfib.org - For Patients. By Patients - Stop Atrial Fibrillation

FDA Warning: Pradaxa Should Not Be Used by Atrial Fibrillation Patients with Mechanical Heart Valves

Good to see the FDA moving on this as we're starting to hear of afib patients with mechanical heart valves getting Pradaxa. Here is the FDA announcement... ISSUE: The U.S. Food and Drug Administration (FDA) is informing health care professionals and the public that the blood thinner (anticoagulant) Pradaxa (dabigatran etexilate mesylate) should not be used …

Read More
StopAfib.org - For Patients. By Patients - Stop Atrial Fibrillation

Top Atrial Fibrillation (Afib) Articles of 2012

StopAfib.org is pleased to unveil the Top Ten Atrial Fibrillation Articles of 2012. There were many topics of interest this year to the atrial fibrillation patient community. As always, the top interest was atrial fibrillation stroke prevention — that included the CHADS2 and CHA2DS2-VASc scoring tools that determine the need for anticoagulants, the HAS-BLED tool …

Read More
StopAfib.org - For Patients. By Patients - Stop Atrial Fibrillation

The FACT Alliance Supports Access to Life-saving Technologies for Atrial Fibrillation Patients

StopAfib.org has joined the Fair Access to Cardiac Technology (FACT) Alliance to raise awareness of the importance of access to this medical technology for the detection of atrial fibrillation and other arrhythmias. The FACT Alliance has started a petition to ensure that everyone has access to this potentially life-saving Mobile Cardiac Telemetry (MCT) technology. Learn …

Read More
StopAfib.org - For Patients. By Patients - Stop Atrial Fibrillation

Do you have atrial fibrillation? Your input can help shape research to benefit afib patients.

Patients with atrial fibrillation are at higher risk of suffering stroke and other complications related to the development of blood clots in their heart. Until 2010, the only oral anticoagulant (blood thinner) to prevent strokes in Afib was warfarin (Coumadin®). Now there are two new oral anticoagulants available in the United States--dabigatran (Pradaxa®) and rivaroxaban …

Read More
StopAfib.org - For Patients. By Patients - Stop Atrial Fibrillation

Living with Atrial Fibrillation programs from American College of Cardiology’s (ACC) CardioSmart initiative & Mended Hearts

In December of 2012, the American College of Cardiology’s (ACC) CardioSmart initiative and Mended Hearts will be sponsoring three Living with Atrial Fibrillation programs in Dallas, Houston, and Tampa. Learn more at: American College of Cardiology’s (ACC) CardioSmart initiative and Mended Hearts are sponsoring Living with Atrial Fibrillation programs

Read More